September 15, 2023 12:22 PM EDT
Pharma
Marketing

Most phar­ma com­pa­nies are not ‘fu­ture ready’ as pres­sure mounts from AI ad­vances and IRA leg­is­la­tion, sur­vey finds

Beth Snyder Bulik

Senior Editor

Phar­ma is not ready for the fu­ture. On­ly 10% say they’re “fu­ture ready,” ac­cord­ing to a re­cent sur­vey of phar­ma­ceu­ti­cal lead­ers by In­de­gene. That’s a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times